Criteria and Scoring Functions Used in Multi-criteria Decision Analysis and Value Frameworks for the Assessment of Rare Disease Therapies: A Systematic Literature Review

BACKGROUND: Traditionally, the economic value of health technologies is assessed with cost-effectiveness (CE) and budget impact (BI) analyses. However, the evaluation of rare disease therapies often considers novel value criteria. Multi-criteria decision analysis (MCDA) is a promising tool in the as...

Descripción completa

Detalles Bibliográficos
Autores principales: Zelei, Tamás, Mendola, Nicholas D., Elezbawy, Baher, Németh, Bertalan, Campbell, Jonathan D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8611126/
https://www.ncbi.nlm.nih.gov/pubmed/34003484
http://dx.doi.org/10.1007/s41669-021-00271-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8611126/
https://www.ncbi.nlm.nih.gov/pubmed/34003484
http://dx.doi.org/10.1007/s41669-021-00271-w

Ejemplares similares